Development and Optimization of Ferrous Fumarate Chewable Tablets by Simplex Experimental Design Ferrous fumarate chewable tablet formulation by experimental design
Iranian Journal of Pharmaceutical Sciences,
Vol. 9 No. 2 (2013),
1 April 2013
,
Page 49-66
https://doi.org/10.22037/ijps.v9.40901
Abstract
Chewable ferrous fumarate tablet is the best iron dosage form for children due to better compliance and lower teeth staining compared to the oral drop. Because of the different desirable properties of chewable tablets and the opposing effects of fillers on them, the mathematical experimental design was used as the formulation approach. Different series of formulations based on single filler (Lactose granule, mannitol granule, and three Avicels) were prepared and evaluated. The total filler percentage in formulation was kept constant at 40% and simplex lattice mixture design was used with percentages of each of the three selected fillers as factors and hardness, friability, and taste of the resulted tablets as responses. The statistical analysis and optimization were performed by Design Expert software using responses in suggested experimental runs. Two-way analysis of variance and Scheffe Post-Hoc test showed that both the type and amount of fillers were effective on hardness and had interaction. Avicel PH301 was selected as the filler for imparting higher hardness, and lactose and mannitol granules for imparting good taste and mouth feel to tablets. The proper models for the relationship between the three factors and each of the three responses were determined and the regarding equations were suggested. The mathematical optimization suggested the acceptable formulations of ferrous fumarate chewable tablets. The mathematical experimental design is suggested as a promising efficient method for optimization of pharmaceutical formulation projects with multiple goals.
- Chewable Tablet
- Experimental Design
- Ferrous Fumarate
- Formulation
- Optimization
- Simplex Lattice
How to Cite
References
[2] Lewis GA, Mathieu D, Phan-Than-Luu R. Pharmaceutical Experimental Design, Marcel Decker Inc.: New York (1999).
[3] Introduction to Experimental Design. Armstrong NA (Ed.) In: Pharmaceutical Experimental design and Interpretation, 2nd ed., Taylor and Francis, London (2006) 1-8.
[4] Duque MD, Kreidel RN, Taqueda ME, Baby AR, Kaneko TM, Velasco MV, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharm Dev Technol. 2013; 18: 1247-1254.
[5] Vaghani SS, Patel SG, Jivani RR, Jivani NP, Patel MM, Borda R. Design and optimization of a stomach-specific drug delivery system of repaglinide: application of simplex lattice design. Pharm Dev Technol. 2012; 17: 55-65.
[6] Mehta S, De Beer T, Remon JP, Vervaet C. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules. Int J Pharm. 2012; 422: 310– 317.
[7] Chaibva FA, Walker RB. The use of response surface methodology for the formulation and optimization of sulbutamol sulfate hydrophilic matrix sustained release tablets. Pharm DevTechnol. 2012; 17: 594-606.
[8] Shin S, Choi DH, Truong NKV, Kim NA, Chu KR, Jeong SH. Time-oriented experimental design method to optimize hydrophilic matrix formulations with gelation kinetics and drug release profiles. Int J Pharm. 2011; 407: 53-62.
[9] Bolourchian N, Hadidi N, Foroutan SM, Shafaghi B. Development and optimization of a sublingual tablet formulation for physostigmine salicylate. Acta Pharm. 2009; 59: 301–312.
[10] Martinello T, Kaneko TM, Velasco MVR, Taqueda MES, Consiglieri VO. Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design. Int J Pharm. 2006; 322: 87-95.
[11] Fernandez EG, Cordero S, Benitez M, Perdomo I, Moron Y, Morales AE, Arce MG, Cuesta E, Lugones J, Fernandez M, Gil A, Valdes R, Fernandez M. Rapid development and optimization of tablet manufacturing using statistical tools. AAPS PharmSciTech 2008; 9: 620-627.
[12] Perissutti B, Rubessa F, Moneghini M, Voinovich D. Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique. Int J Pharm. 2003; 256: 53-63.
[13] Furlanetto S, Cirri M, Piepel G, Mennini N, Mura P. Mixture experiment methods in the development and optimization of microemulsion formulations. J Pharm Biomed Anal. 2011; 55: 610-617.
[14] Mura P, Furlanetto S, Cirri M, Maestrelli F, Marras AM, and Pinzauti S. Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental design. J Pharm Biomed Anal. 2005; 37: 65-71.
[15] Busignies V, Leclerc B, Porion P, Evesque P, Couarraze G, Tchoreloff P. Compaction behavior and new predictive approach to the compressibility of binary mixtures of pharmaceutical excipients. European J Pharm Biopharm. 2006; 64: 66-74.
[16] Mohammed H, Briscoe BJ, Pitt KG. A study on the coherence of compacted binary composites of microcrystalline cellulose and paracetamol. European J Pharm Biopharm. 2006; 63: 19-25.
- Abstract Viewed: 416 times
- IJPS_Volume 9_Issue 2_Pages 49-66 Downloaded: 352 times